A clinical-stage Nrf2 activator suppresses osteoclast differentiation via the iron-ornithine axis.
Dong Y, Kang H, Peng R, Liu Z, Liao F, Hu SA, Ding W, Wang P, Yang P, Zhu M, Wang S, Wu M, Ye D, Gan X, Li F, Song K.
Dong Y, et al. Among authors: zhu m.
Cell Metab. 2024 Mar 28:S1550-4131(24)00084-6. doi: 10.1016/j.cmet.2024.03.005. Online ahead of print.
Cell Metab. 2024.
PMID: 38569557